Lukas Hingerl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lukas Hingerl has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Wolfgang Bogner
High Field MR Center, Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria
29 shared publications - Bernhard Strasser
High Field MR Center, Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria
22 shared publications - Gilbert Hangel
Department of Neurosurgery, Medical University of Vienna, Vienna, Austria
21 shared publications - Siegfried Trattnig
High Field MR Center, Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria
18 shared publications - Stanislav Motyka
High Field MR Center, Department of Biomedical Imaging and Image‐guided Therapy Medical University of Vienna Vienna Austria
10 shared publications - Fabian Niess
High-field MR Center, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
9 shared publications
Latest Publications
- Open Access
Glutamine and NAA dissociate in ALS across somatotopically defined motor regions using 7T MRSI
Amyotrophic lateral sclerosis (ALS) is increasingly understood as a progressive neurodegenerative disorder with distributed cortical and subcortical involvement, but in vivo metabolic mapping has been limited by the spatial coverage of single-voxel proton magnetic resonance spectroscopy (MRS). We acquired high-resolution whole-brain 7T 3D-CRT-FID-MRSI alongside motor-cortex single-voxel sLASER in five rapidly progressing people living with ALS (plALS) and seven non-neurodegenerative controls (NCs), with up to three sessions per participant. Regional metabolite ratios (N-Acetylaspartate [tNAA], glutamate [Glu], glutamine [Gln] to creatine [tCr], and Glu+Gln [Glx] to tNAA) were modelled with Bayesian hierarchical mixed-effects models, and the primary motor cortex was subdivided along its dorsoventral somatotopic axis (bulbar/face, hand/upper-limb, foot/lower-limb). At baseline, plALS showed a motor-cortex-selective tNAA/tCr deficit (motor composite −8.7%, 95% credible Interval [CrI] −16.1 to −1.1, posterior probability=0.99) accompanied by cortically diffuse glutamatergic elevation (Gln/tCr +25.6%, posterior probability=0.96; Glx/tNAA +10.4%, posterior probability=0.95). Reliable separation of the J-coupled glutamine and glutamate resonances at 7T revealed Gln/tCr as a more sensitive marker of glutamatergic dysregulation than Glu/tCr alone in this cohort. Within the somatotopic subdivision, all five plALS showed their peak Gln/tCr increase in the bulbar/face zone irrespective of clinical onset, including three lower-limb-onset patients. Annualised metabolite slope by zone correlated with the matched ALSFRS-R domain decline (Glx/tNAA r=0.82, p<0.001). Group-level longitudinal interactions were modest. Bayesian assurance simulations indicated Glx/tNAA as the most efficient candidate primary endpoint for a confirmatory cross-sectional study. These findings demonstrate that 7T whole-brain MRSI can resolve a metabolic dissociation between motor-selective neuronal compromised and somatotopically patterned glutamatergic dysregulation in ALS and provide design-ready endpoint and sample-size guidance for utility as a structural biomarker of brain function in clinical trials.
Open AccessGlutamine and NAA dissociate in ALS across somatotopically defined motor regions using 7T MRSI
Amyotrophic lateral sclerosis (ALS) is increasingly understood as a progressive neurodegenerative disorder with distributed cortical and subcortical involvement, but in vivo metabolic mapping has been limited by the spatial coverage of single-voxel proton magnetic resonance spectroscopy (MRS). We acquired high-resolution whole-brain 7T 3D-CRT-FID-MRSI alongside motor-cortex single-voxel sLASER in five rapidly progressing people living with ALS (plALS) and seven non-neurodegenerative controls (NCs), with up to three sessions per participant. Regional metabolite ratios (N-Acetylaspartate [tNAA], glutamate [Glu], glutamine [Gln] to creatine [tCr], and Glu+Gln [Glx] to tNAA) were modelled with Bayesian hierarchical mixed-effects models, and the primary motor cortex was subdivided along its dorsoventral somatotopic axis (bulbar/face, hand/upper-limb, foot/lower-limb). At baseline, plALS showed a motor-cortex-selective tNAA/tCr deficit (motor composite −8.7%, 95% credible Interval [CrI] −16.1 to −1.1, posterior probability=0.99) accompanied by cortically diffuse glutamatergic elevation (Gln/tCr +25.6%, posterior probability=0.96; Glx/tNAA +10.4%, posterior probability=0.95). Reliable separation of the J-coupled glutamine and glutamate resonances at 7T revealed Gln/tCr as a more sensitive marker of glutamatergic dysregulation than Glu/tCr alone in this cohort. Within the somatotopic subdivision, all five plALS showed their peak Gln/tCr increase in the bulbar/face zone irrespective of clinical onset, including three lower-limb-onset patients. Annualised metabolite slope by zone correlated with the matched ALSFRS-R domain decline (Glx/tNAA r=0.82, p<0.001). Group-level longitudinal interactions were modest. Bayesian assurance simulations indicated Glx/tNAA as the most efficient candidate primary endpoint for a confirmatory cross-sectional study. These findings demonstrate that 7T whole-brain MRSI can resolve a metabolic dissociation between motor-selective neuronal compromised and somatotopically patterned glutamatergic dysregulation in ALS and provide design-ready endpoint and sample-size guidance for utility as a structural biomarker of brain function in clinical trials.
- Open Access
- 21 May 2026
- Published by Elsevier in SSRN Electronic Journal
7T MRSI identifies metabolically distinct multiple sclerosis lesion phenotypes associated with disability
Multiple sclerosis lesions are heterogeneous, but their in vivo metabolic characteristics remain poorly defined. We used 7T MR spectroscopic imaging to determine whether white matter lesions can be stratified based on metabolic patterns and whether these relate to paramagnetic rim status, normal-appearing white matter metabolism, and clinical disability. In this cross-sectional study, 50 people with multiple sclerosis underwent 7T MR imaging, including 3D spectroscopic imaging. After quality control, 304 white matter lesions from 45 participants were analyzed for metabolite ratios reflecting redox balance, gliosis, and neuronal integrity. Lesions were grouped using unsupervised clustering, and associations with imaging features and clinical outcomes were assessed. Three reproducible lesion clusters emerged, showing distinct metabolic patterns consistent with inflammation, metabolic exhaustion, and partial repair. Paramagnetic rim lesions were most frequent in the inflammatory cluster and least frequent in the repair-like cluster. Repair-like lesions were associated with higher antioxidative capacity in normal-appearing white matter. In contrast, lesions characterized by inflammatory and metabolic exhaustion patterns were associated with worse cognitive and motor performance, whereas repair-like lesions were not associated with disability. These findings demonstrate that 7T spectroscopic imaging identifies metabolically distinct lesion phenotypes reflecting heterogeneous pathological processes with different clinical consequences. Metabolic characterization of lesions provides clinically relevant information beyond lesion detection and may improve monitoring of disease progression in multiple sclerosis.
- 21 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open Access7T MRSI identifies metabolically distinct multiple sclerosis lesion phenotypes associated with disability
Multiple sclerosis lesions are heterogeneous, but their in vivo metabolic characteristics remain poorly defined. We used 7T MR spectroscopic imaging to determine whether white matter lesions can be stratified based on metabolic patterns and whether these relate to paramagnetic rim status, normal-appearing white matter metabolism, and clinical disability. In this cross-sectional study, 50 people with multiple sclerosis underwent 7T MR imaging, including 3D spectroscopic imaging. After quality control, 304 white matter lesions from 45 participants were analyzed for metabolite ratios reflecting redox balance, gliosis, and neuronal integrity. Lesions were grouped using unsupervised clustering, and associations with imaging features and clinical outcomes were assessed. Three reproducible lesion clusters emerged, showing distinct metabolic patterns consistent with inflammation, metabolic exhaustion, and partial repair. Paramagnetic rim lesions were most frequent in the inflammatory cluster and least frequent in the repair-like cluster. Repair-like lesions were associated with higher antioxidative capacity in normal-appearing white matter. In contrast, lesions characterized by inflammatory and metabolic exhaustion patterns were associated with worse cognitive and motor performance, whereas repair-like lesions were not associated with disability. These findings demonstrate that 7T spectroscopic imaging identifies metabolically distinct lesion phenotypes reflecting heterogeneous pathological processes with different clinical consequences. Metabolic characterization of lesions provides clinically relevant information beyond lesion detection and may improve monitoring of disease progression in multiple sclerosis.
- Open Access
- 3 March 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 111, 104014
PHIVE: A physics-informed variational encoder enables rapid spectral fitting of brain metabolite mapping at 7T
- 3 March 2026
- Published by Elsevier in Medical Image Analysis
- Vol. 111, 104014
Open AccessPHIVE: A physics-informed variational encoder enables rapid spectral fitting of brain metabolite mapping at 7T
- Open Access
A Deep Autoencoder for Fast Spectral-Temporal Fitting of Dynamic Deuterium Metabolic Imaging Data at 7T
Deuterium metabolic imaging (DMI) is a non-invasive magnetic resonance spectroscopic imaging technique enabling in vivo mapping of glucose metabolism. Dynamic DMI provides time-resolved metabolite maps and allows spatially resolved fitting of metabolic models to capture metabolite concentration dynamics. However, conventional fitting tools often require long processing times for high-resolution datasets, limiting their practical utility. To address this bottleneck, we propose a deep autoencoder (DAE) for rapid spectral–temporal fitting of dynamic DMI data, supporting arbitrary parametric model constraints to describe metabolite concentration dynamics. The DAE was benchmarked against spectral-temporal fitting using FSL-MRS and LCModel. Fitting accuracy was evaluated on in vivo and synthetic whole-brain dynamic DMI data acquired at 7T using Bland-Altman metrics, Pearson correlation coefficients, structural similarity index measures, and root mean squared errors for both metabolite concentrations and model constraint parameters. The DAE achieved processing times of 0.29 ms per voxel, corresponding to an acceleration of more than three orders of magnitude compared to LCModel/FSL-MRS (0.55/0.65 s per voxel). On in vivo data, it showed excellent agreement with LCModel, and on synthetic data, it consistently outperformed both reference methods across all evaluation metrics. The proposed DAE enables accurate spectral-temporal fitting for whole-brain dynamic DMI scans within less than a second, matching or exceeding the performance of conventional state-of-the-art fitting methods. This makes it a promising tool for integration into efficient post-processing pipelines for research and clinical DMI workflows.
Open AccessA Deep Autoencoder for Fast Spectral-Temporal Fitting of Dynamic Deuterium Metabolic Imaging Data at 7T
Deuterium metabolic imaging (DMI) is a non-invasive magnetic resonance spectroscopic imaging technique enabling in vivo mapping of glucose metabolism. Dynamic DMI provides time-resolved metabolite maps and allows spatially resolved fitting of metabolic models to capture metabolite concentration dynamics. However, conventional fitting tools often require long processing times for high-resolution datasets, limiting their practical utility. To address this bottleneck, we propose a deep autoencoder (DAE) for rapid spectral–temporal fitting of dynamic DMI data, supporting arbitrary parametric model constraints to describe metabolite concentration dynamics. The DAE was benchmarked against spectral-temporal fitting using FSL-MRS and LCModel. Fitting accuracy was evaluated on in vivo and synthetic whole-brain dynamic DMI data acquired at 7T using Bland-Altman metrics, Pearson correlation coefficients, structural similarity index measures, and root mean squared errors for both metabolite concentrations and model constraint parameters. The DAE achieved processing times of 0.29 ms per voxel, corresponding to an acceleration of more than three orders of magnitude compared to LCModel/FSL-MRS (0.55/0.65 s per voxel). On in vivo data, it showed excellent agreement with LCModel, and on synthetic data, it consistently outperformed both reference methods across all evaluation metrics. The proposed DAE enables accurate spectral-temporal fitting for whole-brain dynamic DMI scans within less than a second, matching or exceeding the performance of conventional state-of-the-art fitting methods. This makes it a promising tool for integration into efficient post-processing pipelines for research and clinical DMI workflows.
- Open Access
- 1 September 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (5) , e240494
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSI
The 7-T MR spectroscopic imaging revealed increased glutamate and glutamine metabolic ratios within the peritumoral region compared with normal-appearing white matter in patients with glioma distinct from intratumoral changes, suggesting its potential clinical application for imaging glioma infiltration.
- 1 September 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (5) , e240494
Open AccessHigh-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSI
The 7-T MR spectroscopic imaging revealed increased glutamate and glutamine metabolic ratios within the peritumoral region compared with normal-appearing white matter in patients with glioma distinct from intratumoral changes, suggesting its potential clinical application for imaging glioma infiltration.
- Open Access
- 8 January 2025
- Published by Elsevier in NeuroImage
- Vol. 307, 121015
Exploring in vivo human brain metabolism at 10.5 T: Initial insights from MR spectroscopic imaging
- 8 January 2025
- Published by Elsevier in NeuroImage
- Vol. 307, 121015
Open AccessExploring in vivo human brain metabolism at 10.5 T: Initial insights from MR spectroscopic imaging
- Open Access
PHIVE: A Physics-Informed Variational Encoder Enables Rapid Spectral Fitting of Brain Metabolite Mapping at 7T
Magnetic Resonance Spectroscopic Imaging (MRSI) enables non-invasive mapping of brain metabolite concentrations but remains computationally intensive and challenging due to a low signal-to-noise ratio (SNR) and overlapping spectral features. Traditional spectral fitting methods, such as LCModel, are time-consuming and often lack comprehensive uncertainty quantification. In this study, we propose Physics-Informed Variational Encoder (PHIVE), a novel deep learning framework that integrates physics-based priors into a variational autoencoder architecture for rapid and accurate metabo-lite quantification. PHIVE enables simultaneous estimation of metabolite concentrations and uncertainty metrics, including Cramér-Rao Lower Bound (CRLB), aleatoric, and epistemic uncertainties. PHIVE was evaluated on whole-brain MRSI data from 7T acquisitions of healthy controls. The method achieved comparable accuracy to LCModel for key metabolites, such as Total N-acetylaspartate (tNAA), Glutamate-Glutamine complex (Glx), and Myo-inositol (mIns) while demonstrating a six-order magnitude reduction in computational time (6 ms per dataset). Uncertainty quantification highlighted PHIVE’s robustness in regions with low SNR. Additionally, a conditional baseline modeling approach was introduced, enabling dynamic flexibility in spectral baseline estimation during inference time. These results suggest that PHIVE offers a fast, reliable, and interpretable solution for high-resolution metabolite quantification, paving the way for real-time MRSI applications in clinical and research settings. Future work will focus on expanding its validation across diverse datasets and investigating its utility in longitudinal and multicenter studies.
Open AccessPHIVE: A Physics-Informed Variational Encoder Enables Rapid Spectral Fitting of Brain Metabolite Mapping at 7T
Magnetic Resonance Spectroscopic Imaging (MRSI) enables non-invasive mapping of brain metabolite concentrations but remains computationally intensive and challenging due to a low signal-to-noise ratio (SNR) and overlapping spectral features. Traditional spectral fitting methods, such as LCModel, are time-consuming and often lack comprehensive uncertainty quantification. In this study, we propose Physics-Informed Variational Encoder (PHIVE), a novel deep learning framework that integrates physics-based priors into a variational autoencoder architecture for rapid and accurate metabo-lite quantification. PHIVE enables simultaneous estimation of metabolite concentrations and uncertainty metrics, including Cramér-Rao Lower Bound (CRLB), aleatoric, and epistemic uncertainties. PHIVE was evaluated on whole-brain MRSI data from 7T acquisitions of healthy controls. The method achieved comparable accuracy to LCModel for key metabolites, such as Total N-acetylaspartate (tNAA), Glutamate-Glutamine complex (Glx), and Myo-inositol (mIns) while demonstrating a six-order magnitude reduction in computational time (6 ms per dataset). Uncertainty quantification highlighted PHIVE’s robustness in regions with low SNR. Additionally, a conditional baseline modeling approach was introduced, enabling dynamic flexibility in spectral baseline estimation during inference time. These results suggest that PHIVE offers a fast, reliable, and interpretable solution for high-resolution metabolite quantification, paving the way for real-time MRSI applications in clinical and research settings. Future work will focus on expanding its validation across diverse datasets and investigating its utility in longitudinal and multicenter studies.
- Open Access
- 19 December 2024
- Published by Wiley in NMR in Biomedicine
- Vol. 38 (2) , e5311
Concentric Ring Trajectory Sampling With k‐Space Reordering Enables Assessment of Tissue‐Specific T1 and T2 Relaxation for 2H‐Labeled Substrates in the Human Brain at 7 T
Deuterium metabolic imaging (DMI) is an emerging Magnetic Resonance technique providing valuable insight into the dynamics of cellular glucose (Glc) metabolism of the human brain in vivo using deuterium‐labeled (2H) glucose as non‐invasive tracer. Reliable concentration estimation of 2H‐Glc and downstream synthesized neurotransmitters glutamate + glutamine (Glx) requires accurate knowledge of relaxation times, but so far tissue‐specific T1 and T2 relaxation times (e.g., in gray and white matter) have not been determined. Such measurements are time‐consuming and particularly challenging in the presence of dynamically changing metabolite levels (e.g. 2H Glc and 2H Glx).This study aimed to assess T1 and T2 relaxation times of deuterated resonances, i.e., water, Glc and Glx in human gray and white matter using inversion recovery and Hahn spin‐echo 2H MRSI (magnetic resonance spectroscopic imaging), respectively, with non‐Cartesian concentric ring trajectory readout (CRT) including specific k‐space reordering at 7 T. The sequence was validated using phantom measurements and all results were compared to unlocalized acquisitions. Thirteen healthy volunteers participated in the study, with 10 of them scanned ~90 min after oral administration of 0.8 g/kg [6,6′‐2H]‐glucose. Significantly different T1 and T2 relaxation was observed between GM and WM for 2H water (T1GM/WM/unlocalized = 358 ± 21/328 ± 12/335 m ± 6 ms, p = 0.01) and 2H Glx (T2GM/WM/unlocalized = 37 ± 2/35 ± 2/33 ± 3 ms, p = 0.02), respectively, consistent with unlocalized acquisitions. No significant regional differences were found for 2H water (T2GM/WM/unlocalized = 36 ± 2/34 ± 2/31 ± 2 ms, p = 0.08), 2H Glc (T1GM/WM/unlocalized = 70 ± 5/73 ± 4/80 ± 5 ms, p = 0.13; T2GM/WM/unlocalized = 36 ± 1/34 ± 2/34 ± 2 ms, p = 0.24) and Glx (T1GM/WM/unlocalized = 172 ± 15/172 ± 12/165 ± 11 ms, p = 1.00).Knowledge of tissue‐specific relaxation times can enhance the accuracy of concentration estimation and metabolic flux rates in future studies, potentially improving our understanding of various brain diseases such as cancer, neurodegenerative diseases or diabetes, which are often linked to impaired glucose metabolism.
- 19 December 2024
- Published by Wiley in NMR in Biomedicine
- Vol. 38 (2) , e5311
Open AccessConcentric Ring Trajectory Sampling With k‐Space Reordering Enables Assessment of Tissue‐Specific T1 and T2 Relaxation for 2H‐Labeled Substrates in the Human Brain at 7 T
Deuterium metabolic imaging (DMI) is an emerging Magnetic Resonance technique providing valuable insight into the dynamics of cellular glucose (Glc) metabolism of the human brain in vivo using deuterium‐labeled (2H) glucose as non‐invasive tracer. Reliable concentration estimation of 2H‐Glc and downstream synthesized neurotransmitters glutamate + glutamine (Glx) requires accurate knowledge of relaxation times, but so far tissue‐specific T1 and T2 relaxation times (e.g., in gray and white matter) have not been determined. Such measurements are time‐consuming and particularly challenging in the presence of dynamically changing metabolite levels (e.g. 2H Glc and 2H Glx).This study aimed to assess T1 and T2 relaxation times of deuterated resonances, i.e., water, Glc and Glx in human gray and white matter using inversion recovery and Hahn spin‐echo 2H MRSI (magnetic resonance spectroscopic imaging), respectively, with non‐Cartesian concentric ring trajectory readout (CRT) including specific k‐space reordering at 7 T. The sequence was validated using phantom measurements and all results were compared to unlocalized acquisitions. Thirteen healthy volunteers participated in the study, with 10 of them scanned ~90 min after oral administration of 0.8 g/kg [6,6′‐2H]‐glucose. Significantly different T1 and T2 relaxation was observed between GM and WM for 2H water (T1GM/WM/unlocalized = 358 ± 21/328 ± 12/335 m ± 6 ms, p = 0.01) and 2H Glx (T2GM/WM/unlocalized = 37 ± 2/35 ± 2/33 ± 3 ms, p = 0.02), respectively, consistent with unlocalized acquisitions. No significant regional differences were found for 2H water (T2GM/WM/unlocalized = 36 ± 2/34 ± 2/31 ± 2 ms, p = 0.08), 2H Glc (T1GM/WM/unlocalized = 70 ± 5/73 ± 4/80 ± 5 ms, p = 0.13; T2GM/WM/unlocalized = 36 ± 1/34 ± 2/34 ± 2 ms, p = 0.24) and Glx (T1GM/WM/unlocalized = 172 ± 15/172 ± 12/165 ± 11 ms, p = 1.00).Knowledge of tissue‐specific relaxation times can enhance the accuracy of concentration estimation and metabolic flux rates in future studies, potentially improving our understanding of various brain diseases such as cancer, neurodegenerative diseases or diabetes, which are often linked to impaired glucose metabolism.
- Open Access
A Comparison of 7 Tesla MR Spectroscopic Imaging and 3 Tesla MR Fingerprinting for Tumor Localization in Glioma Patients
This paper investigated the correlation between magnetic resonance spectroscopic imaging (MRSI) and magnetic resonance fingerprinting (MRF) in glioma patients by comparing neuro-oncological markers obtained from MRSI to T1/T2 maps from MRF. Data from 12 consenting patients with gliomas were analyzed by defining hotspots for T1, T2, and various metabolic ratios, and comparing them using Sørensen–Dice similarity coefficients (DSCs) and the distances between their centers of intensity (COIDs). The median DSCs between MRF and the tumor segmentation were 0.73 (T1) and 0.79 (T2). The DSCs between MRSI and MRF were the highest for Gln/tNAA (T1: 0.75, T2: 0.80, tumor: 0.78), followed by Gly/tNAA (T1: 0.57, T2: 0.62, tumor: 0.54) and tCho/tNAA (T1: 0.61, T2: 0.58, tumor: 0.45). The median values in the tumor hotspot were T1 = 1724 ms, T2 = 86 ms, Gln/tNAA = 0.61, Gly/tNAA = 0.28, Ins/tNAA = 1.15, and tCho/tNAA = 0.48, and, in the peritumoral region, were T1 = 1756 ms, T2 = 102 ms, Gln/tNAA = 0.38, Gly/tNAA = 0.20, Ins/tNAA = 1.06, and tCho/tNAA = 0.38, and, in the NAWM, were T1 = 950 ms, T2 = 43 ms, Gln/tNAA = 0.16, Gly/tNAA = 0.07, Ins/tNAA = 0.54, and tCho/tNAA = 0.20. The results of this study constitute the first comparison of 7T MRSI and 3T MRF, showing a good correspondence between these methods.
Open AccessA Comparison of 7 Tesla MR Spectroscopic Imaging and 3 Tesla MR Fingerprinting for Tumor Localization in Glioma Patients
This paper investigated the correlation between magnetic resonance spectroscopic imaging (MRSI) and magnetic resonance fingerprinting (MRF) in glioma patients by comparing neuro-oncological markers obtained from MRSI to T1/T2 maps from MRF. Data from 12 consenting patients with gliomas were analyzed by defining hotspots for T1, T2, and various metabolic ratios, and comparing them using Sørensen–Dice similarity coefficients (DSCs) and the distances between their centers of intensity (COIDs). The median DSCs between MRF and the tumor segmentation were 0.73 (T1) and 0.79 (T2). The DSCs between MRSI and MRF were the highest for Gln/tNAA (T1: 0.75, T2: 0.80, tumor: 0.78), followed by Gly/tNAA (T1: 0.57, T2: 0.62, tumor: 0.54) and tCho/tNAA (T1: 0.61, T2: 0.58, tumor: 0.45). The median values in the tumor hotspot were T1 = 1724 ms, T2 = 86 ms, Gln/tNAA = 0.61, Gly/tNAA = 0.28, Ins/tNAA = 1.15, and tCho/tNAA = 0.48, and, in the peritumoral region, were T1 = 1756 ms, T2 = 102 ms, Gln/tNAA = 0.38, Gly/tNAA = 0.20, Ins/tNAA = 1.06, and tCho/tNAA = 0.38, and, in the NAWM, were T1 = 950 ms, T2 = 43 ms, Gln/tNAA = 0.16, Gly/tNAA = 0.07, Ins/tNAA = 0.54, and tCho/tNAA = 0.20. The results of this study constitute the first comparison of 7T MRSI and 3T MRF, showing a good correspondence between these methods.
- Open Access
- 9 January 2024
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 91 (5) , 2044-2056
Predicting dynamic, motion‐related changes in B0 field in the brain at a 7T MRI using a subject‐specific fine‐trained U‐net
Purpose: Subject movement during the MR examination is inevitable and causes not only image artifacts but also deteriorates the homogeneity of the main magnetic field (B0), which is a prerequisite for high quality data. Thus, characterization of changes to B0, for example induced by patient movement, is important for MR applications that are prone to B0 inhomogeneities.Methods: We propose a deep learning based method to predict such changes within the brain from the change of the head position to facilitate retrospective or even real‐time correction. A 3D U‐net was trained on in vivo gradient‐echo brain 7T MRI data. The input consisted of B0 maps and anatomical images at an initial position, and anatomical images at a different head position (obtained by applying a rigid‐body transformation on the initial anatomical image). The output consisted of B0 maps at the new head positions. We further fine‐trained the network weights to each subject by measuring a limited number of head positions of the given subject, and trained the U‐net with these data.Results: Our approach was compared to established dynamic B0 field mapping via interleaved navigators, which suffer from limited spatial resolution and the need for undesirable sequence modifications. Qualitative and quantitative comparison showed similar performance between an interleaved navigator‐equivalent method and proposed method.Conclusion: It is feasible to predict B0 maps from rigid subject movement and, when combined with external tracking hardware, this information could be used to improve the quality of MR acquisitions without the use of navigators.
- 9 January 2024
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 91 (5) , 2044-2056
Open AccessPredicting dynamic, motion‐related changes in B0 field in the brain at a 7T MRI using a subject‐specific fine‐trained U‐net
Purpose: Subject movement during the MR examination is inevitable and causes not only image artifacts but also deteriorates the homogeneity of the main magnetic field (B0), which is a prerequisite for high quality data. Thus, characterization of changes to B0, for example induced by patient movement, is important for MR applications that are prone to B0 inhomogeneities.Methods: We propose a deep learning based method to predict such changes within the brain from the change of the head position to facilitate retrospective or even real‐time correction. A 3D U‐net was trained on in vivo gradient‐echo brain 7T MRI data. The input consisted of B0 maps and anatomical images at an initial position, and anatomical images at a different head position (obtained by applying a rigid‐body transformation on the initial anatomical image). The output consisted of B0 maps at the new head positions. We further fine‐trained the network weights to each subject by measuring a limited number of head positions of the given subject, and trained the U‐net with these data.Results: Our approach was compared to established dynamic B0 field mapping via interleaved navigators, which suffer from limited spatial resolution and the need for undesirable sequence modifications. Qualitative and quantitative comparison showed similar performance between an interleaved navigator‐equivalent method and proposed method.Conclusion: It is feasible to predict B0 maps from rigid subject movement and, when combined with external tracking hardware, this information could be used to improve the quality of MR acquisitions without the use of navigators.